# Paediatric Safety Study in Cat-PAD

> **NCT01921257** · PHASE2 · COMPLETED · sponsor: **Circassia Limited** · enrollment: 16 (actual)

## Conditions studied

- Rhinoconjunctivitis

## Interventions

- **DRUG:** Cat-PAD
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01921257
- **Lead sponsor:** Circassia Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2018-05-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01921257

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01921257, "Paediatric Safety Study in Cat-PAD". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01921257. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*